- Home
- BMO vs BSX Comparison
BMO vs BSX Comparison
Compare BMO & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BMO | BSX |
|---|---|---|
| Founded | 1817 | 1979 |
| Country | Canada | United States |
| Employees | 53000 | N/A |
| Industry | Commercial Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.4B | 93.4B |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | BMO | BSX |
|---|---|---|
| Price | $162.82 | $50.58 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 22 |
| Target Price | ★ $163.00 | $93.18 |
| AVG Volume (30 Days) | 877.8K | ★ 15.7M |
| Earning Date | 05-27-2026 | 04-22-2026 |
| Dividend Yield | ★ 3.25% | N/A |
| EPS Growth | N/A | ★ 55.20 |
| EPS | N/A | ★ 0.90 |
| Revenue | N/A | ★ $9,076,000,000.00 |
| Revenue This Year | $19.43 | $11.85 |
| Revenue Next Year | $4.27 | $10.16 |
| P/E Ratio | ★ $17.46 | $64.27 |
| Revenue Growth | N/A | ★ 12.49 |
| 52 Week Low | $105.04 | $52.52 |
| 52 Week High | $163.12 | $109.50 |
Technical Indicators
Market Signals| Indicator | BMO | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 72.96 | 31.13 |
| Support Level | $147.71 | N/A |
| Resistance Level | N/A | $58.18 |
| Average True Range (ATR) | 2.63 | 1.68 |
| MACD | 0.74 | 0.31 |
| Stochastic Oscillator | 96.80 | 4.60 |
Price Performance
Historical ComparisonAbout BMO Bank Of Montreal
Bank of Montreal is a diversified financial services provider based in North America with over CAD 1.47 trillion in assets by the end of fiscal 2025. BMO operates four business segments: Canadian personal and commercial banking, US personal and commercial banking, wealth management, and capital markets. The bank's operations are primarily in Canada, with a material portion also in the US.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.